Estimation of Respiratory Syncytial Virus-attributable Hospitalizations among Older Adults in Japan between 2015 and 2018: an Administrative Health Claims Database Analysis
Seki, M.; Kobayashi, Y.; Meroc, E.; Kitano, T.; Polkowska-Kramek, A.; Yoshida, A.; Ito, S.; Liang, C.; Bruyndonckx, R.; Moges, S. M.; Conde-Sousa, E.; Nuttens, C.; Gessner, B. D.; Begier, E.
Show abstract
ObjectiveWe estimated the incidence rates (IRs) of respiratory syncytial virus (RSV)-related hospitalizations among adults aged [≥]60 years in Japan from 2015 to 2018, using a model-based approach to better understand the disease burden. MethodsWe obtained hospitalization data from the Medical Data Vision (MDV) database, restricted to Diagnosis Procedure Combination (DPC) hospitals. We estimated the annual age-specific RSV-attributable IR of hospitalizations for five cardiorespiratory outcomes based on selected ICD-10 codes employing a quasi-Poisson regression model. We projected our results to all DPC hospitals in Japan and also to all Japanese hospitals. ResultsIn adults aged [≥]60 years, the annual IR of RSV-attributable cardiorespiratory hospitalizations at DPC hospitals was estimated at between 100 and 124 per 100,000 person-years, projecting to 134 to 229 cardiorespiratory hospitalizations per 100,000 person-years at all hospitals. For respiratory hospitalizations at DPC hospitals, the annual IR was from 69 to 85 per 100,000 person-years (projecting to 96 to 157 hospitalizations per 100,000 person-years at all hospitals). IRs for all outcomes were consistently higher among adults aged [≥]80 years than those 60-79 years. ConclusionOur results indicate a high burden of RSV-attributable hospitalizations in older adults in Japan, highlighting the need to implement effective RSV prevention strategies. HighlightsO_LIRSV-attributable hospitalizations were estimated among older adults in Japan C_LIO_LIWe used data from national hospitals and a comprehensive list of ICD-10 codes C_LIO_LIWe performed a time series analysis utilizing a quasi-Poisson regression model C_LIO_LIRSV causes significant cardiorespiratory hospitalizations in older adults C_LIO_LIFuture RSV burden studies should consider respiratory and cardiovascular outcomes C_LI
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Inpatient Burden of Respiratory Syncytial Virus Infection and Influenza in Children Younger than 5 years in Japan, 2011-2022: A database study 96%
- Unveiling the spectrum of Respiratory Syncytial Virus disease in Adults: from Community to Hospital 95%
- Predictors of all-cause mortality among patients hospitalized with influenza, respiratory syncytial virus, or SARS-CoV-2 93%
Similar papers in this journal
- Intrinsic and effective severity of COVID-19 cases infected with the ancestral strain and Omicron BA.2 variant in Hong Kong 94%
- Estimated population-level impact of pneumococcal conjugate vaccines against all-cause pneumonia mortality among unvaccinated age groups in five Latin American countries 92%
- Detection of RSV using nasopharyngeal swabs alone underestimates RSV-related hospitalization incidence in adults: the Multispecimen study’s Final Analysis 92%
Similar papers in this journal
- Medium-term impacts of the waves of the COVID-19 epidemic on treatments for non-COVID-19 patients in intensive care units: a retrospective cohort study in Japan 93%
- Acute respiratory distress syndrome after SARS-CoV-2 infection on young adult population: international observational federated study based on electronic health records through the 4CE consortium 92%
- Large-scale cross-sectional seroepidemiologic study of COVID-19 in Japan: Acquisition of herd immunity and the vaccines’ efficacy 92%
Similar papers in this journal
- Efficacy of remdesivir in hospitalised COVID-19 patients in Japan: A large observational study using the COVID-19 Registry Japan 94%
- Changes in pneumococcal deaths in the United States following the COVID-19 pandemic 93%
- Hospitalization of mild cases of community-acquired pneumonia decreased more than severe ones during the COVID-19 epidemic 92%
Similar papers in this journal
- Cost-Effectiveness of Prefusion F Protein-Based Vaccines Against Respiratory Syncytial Virus Disease for Older Adults in the United States 93%
- The Nicaraguan Pediatric Influenza Cohort Study, 2011-2019: influenza incidence, seasonality, and transmission 92%
- Multimorbidity Profiles and Severe In-Hospital Outcomes in Adults with Respiratory Syncytial Virus 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.